To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 24, 2025

Primary Completion Date

June 11, 2025

Study Completion Date

June 24, 2025

Conditions

Dyslipidemia

Interventions

DRUG

Test Drug

AJU-C714

DRUG

Reference Drug

C714R

Trial Locations (1)

H+ Yangji Hospital, Seoul, Republic of South Korea, Seoul

All Listed Sponsors

lead

AJU Pharm Co., Ltd.

INDUSTRY

NCT06933459 - To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults | Biotech Hunter | Biotech Hunter